![](/wp-content/uploads/2020/05/Allogene-Marketplace-Featured-Images-MMC.png)
$599
Thoughts on Allogene CAR-T Pipeline Update; Q1 2020 Call Summary
On Wednesday, May 6, Allogene held their Q1 2020 earnings call (webcast/press release/ slides), highlighting the off-the-shelf benefits allogeneic products have over autologous products, particularly during the COVID-19 pandemic. Below, FENIX provides thoughts on Allogene’s cell therapy program in the context of the ongoing health emergency.